167.35
price up icon4.46%   7.14
after-market Handel nachbörslich: 164.01 -3.34 -2.00%
loading

Natera Inc Aktie (NTRA) Neueste Nachrichten

pulisher
Oct 04, 2025

Barclays Keeps Their Buy Rating on Natera (NTRA) - The Globe and Mail

Oct 04, 2025
pulisher
Oct 03, 2025

Natera (NTRA): Exploring Valuation as Share Price Pulls Back Despite Strong Growth - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Natera (NTRA): Assessing Valuation Potential as Shares Enter a Quiet Phase - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Chart based exit strategy for Natera Inc.2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How institutional ownership impacts Natera Inc. stock2025 Valuation Update & Safe Capital Growth Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Natera Inc. a candidate for recovery play2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Combining machine learning predictions for Natera Inc.Market Performance Summary & Weekly Breakout Stock Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Natera Stock (NTRA) Opinions on EXPAND Trial Enrollment and Insider Sales - Quiver Quantitative

Oct 02, 2025
pulisher
Oct 02, 2025

Natera CEO Chapman sells $3.7m in stock By Investing.com - Investing.com South Africa

Oct 02, 2025
pulisher
Oct 02, 2025

Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT - BioSpace

Oct 02, 2025
pulisher
Oct 02, 2025

Natera enrolls over 1,600 patients in EXPAND trial for fetal testing - Investing.com Nigeria

Oct 02, 2025
pulisher
Oct 02, 2025

Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus

Oct 02, 2025
pulisher
Oct 01, 2025

Natera (NTRA) sec. Rabinowitz sells $221k in shares By Investing.com - Investing.com Australia

Oct 01, 2025
pulisher
Oct 01, 2025

Natera CFO Brophy sells $403,673 in shares By Investing.com - Investing.com South Africa

Oct 01, 2025
pulisher
Oct 01, 2025

Natera CEO Chapman sells $3.7m in stock - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

Natera (NTRA) sec. Rabinowitz sells $221k in shares - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

Natera CFO Brophy sells $403,673 in shares - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

Natera Inc: president Moshkevich sells $479k in stock By Investing.com - Investing.com South Africa

Oct 01, 2025
pulisher
Oct 01, 2025

Natera Inc: president Moshkevich sells $479k in stock - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

Natera, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

Why Natera’s Stock is Gaining Attention - TipRanks

Oct 01, 2025
pulisher
Oct 01, 2025

Natera (NTRA) Achieves Key Enrollment Milestone in EXPAND Trial - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

Natera enrolls over 1,600 patients in EXPAND trial for fetal testing By Investing.com - Investing.com South Africa

Oct 01, 2025
pulisher
Oct 01, 2025

Major Clinical Trial Milestone: 1,600+ Patients Test Revolutionary Prenatal Screening at Natera - Stock Titan

Oct 01, 2025
pulisher
Oct 01, 2025

Is Natera Inc. building a consolidation baseFed Meeting & Daily Chart Pattern Signal Reports - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer - BioSpace

Oct 01, 2025
pulisher
Oct 01, 2025

Natera’s ctDNA test outperforms standard markers in testicular cancer By Investing.com - Investing.com Nigeria

Oct 01, 2025
pulisher
Sep 30, 2025

Natera’s ctDNA test outperforms standard markers in testicular cancer - Investing.com India

Sep 30, 2025
pulisher
Sep 30, 2025

91.6% Detection Rate: Natera's Breakthrough Study Shows Signatera Test Superior for Testicular Cancer Monitoring - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study Shows - BioSpace

Sep 30, 2025
pulisher
Sep 30, 2025

Natera, Inc. (NASDAQ:NTRA) Given Average Rating of "Buy" by Brokerages - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

GAMMA Investing LLC Acquires 411 Shares of Natera, Inc. $NTRA - Defense World

Sep 30, 2025
pulisher
Sep 29, 2025

Natera's president sells shares worth $117,861 - msn.com

Sep 29, 2025
pulisher
Sep 29, 2025

Natera’s Signatera test shows strong results for uterine cancer monitoring By Investing.com - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

Natera’s Signatera test shows strong results for uterine cancer monitoring - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

SWS Partners Reduces Stake in Natera, Inc. $NTRA - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Natera, Inc. (NTRA) Stock Analysis: Evaluating the 18.92% Upside Potential in Healthcare Diagnostics - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Why Natera Inc. stock remains on buy lists2025 Top Decliners & AI Optimized Trading Strategy Guides - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Natera, Inc. (NTRA) Stock Analysis: 18.92% Potential Upside Amid Robust Revenue Growth - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 27, 2025

Natera, Inc. $NTRA Shares Acquired by Farther Finance Advisors LLC - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

CareDx Asks 3rd Circ. To Rethink $45M False Ad Case - Law360

Sep 26, 2025
pulisher
Sep 26, 2025

Life Beyond the Redwoods: Ciara Bolt at UC San Francisco and NateraUC Santa Cruz - UC Santa Cruz - News

Sep 26, 2025
pulisher
Sep 26, 2025

Wealth Enhancement Advisory Services LLC Has $4.58 Million Holdings in Natera, Inc. $NTRA - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Park Avenue Securities LLC Makes New Investment in Natera, Inc. $NTRA - MarketBeat

Sep 26, 2025
pulisher
Sep 25, 2025

Natera, Inc. Stock Hits Day Low Amid Price Pressure at $163.65 - Markets Mojo

Sep 25, 2025
pulisher
Sep 25, 2025

Stocks making big moves yesterday: Acadia Healthcare, Tesla, THOR Industries, Natera, and P10 - The Globe and Mail

Sep 25, 2025
diagnostics_research LH
$276.94
price down icon 0.89%
diagnostics_research DGX
$179.33
price down icon 0.90%
diagnostics_research WAT
$328.39
price up icon 2.01%
diagnostics_research MTD
$1,314.04
price up icon 1.04%
diagnostics_research IQV
$206.63
price up icon 1.12%
Kapitalisierung:     |  Volumen (24h):